Finzati - Logo
GDTC logo

CytoMed Therapeutics Limited

GDTCBiotechnology
$0.86
-0.02 (-2.15%)
Current price
EarningsLatest report: Dec 31, 2025
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$11.95M
Growth
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.07Healthy liquidity · 5.17Negative growth trendWeak profitability
Financial data as of: Dec 31, 2025, 12:00 AM UTCLast earnings update: Dec 31, 2025, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.86
Change-2.15%
Market Cap$11.95M
52W Range0.68 - 3.68
Beta-0.04
Gross Margin-2.78%
Oper. Margin-14.16%
Profit Margin-12.27%
Debt/Eq0.07
Current Ratio5.17
Quick Ratio5.17
Volume2.03K

Investment DNA

How strong this company looks for long-term investors

34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
49/100
Why this score
Manageable debt level · 0.07Healthy liquidity · 5.17Negative growth trendWeak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 4/14/2023
Industry: Biotechnology
P/B i: 3.07
Debt / Equity i: 0.07
Operating Margin: -1415.96%
Net Margin: -1227.07%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.07
Current Ratio: 5.17
Quick Ratio: 5.17
Status: Good

Insider Transactions

Recent executive and insider activity

Choo Chee Kong
Transaction: 05/13/2026
BUY
Change
+112,000
Price
$1.15
Filing
06/15/2026
Type
BUY
Toh Keng Kiat
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/26/2026
Type
OTHER
Goh Yvonne
Transaction: 03/18/2026
OTHER
Change
0
Price
Not reported
Filing
05/15/2026
Type
OTHER